M. Oishi

发表

Actual usage and clinical effectiveness of insulin preparations in patients with Type 1 diabetes mellitus in Japan: CoDiC-based analysis of clinical data obtained at multiple institutions (JDDM 3).

A. Kanatsuka, K. Hirao, Masashi Kobayashi, 2006, Diabetes research and clinical practice.

Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16

H. Yokoyama, H. Sone, K. Kawai, 2008, Diabetic medicine : a journal of the British Diabetic Association.

Large-scale survey of rates of achieving targets for blood glucose, blood pressure, and lipids and prevalence of complications in type 2 diabetes (JDDM 40)

H. Yokoyama, Y. Kurihara, H. Maegawa, 2016, BMJ Open Diabetes Research and Care.

Time and cost involved in the care of newly registered patients with diabetes mellitus and other lifestyle diseases at diabetes clinics in Japan (JDDM 4)

H. Yokoyama, S. Ikeda, F. Okuguchi, 2007, Diabetic medicine : a journal of the British Diabetic Association.

Chronic kidney disease categories and renal–cardiovascular outcomes in type 2 diabetes without prevalent cardiovascular disease: a prospective cohort study (JDDM25)

F. T. E. Group, K. Sugimoto, H. Yokoyama, 2012, Diabetologia.

Low incidence of cardiovascular events in Japanese patients with Type 2 diabetes in primary care settings: a prospective cohort study (JDDM 20)

H. Yokoyama, H. Sone, M. Matsushima, 2011, Diabetic medicine : a journal of the British Diabetic Association.

Remnant-like particle cholesterol and serum amyloid A-low-density lipoprotein levels in obese subjects with metabolic syndrome.

K. Kotani, A. Shimatsu, H. Yamakage, 2011, Journal of clinical lipidology.

Genetic Background and Clinicopathologic Features of Adult-onset Nephronophthisis

E. Mishima, T. Mochizuki, Y. Ubara, 2021, Kidney international reports.

Glucagon underutilized among type 1 diabetes mellitus patients in Japan.

H. Kitaoka, N. Sakane, M. Furuya, 2013, Diabetes technology & therapeutics.

Liraglutide Versus Sitagliptin in a 24-week, Multicenter, Open-label, Randomized, Parallel-group Study in Japanese Type 2 Diabetes Mellitus Patients Responding Inadequately to a Sulfonylurea and/or One or Two Other Oral Antidiabetic Drugs (JDDM 33)

H. Yokoyama, A. Kashiwagi, K. Yamaguchi, 2014, Japanese clinical medicine.

Trends in glycemic control in patients with insulin therapy compared with non-insulin or no drugs in type 2 diabetes in Japan: a long-term view of real-world treatment between 2002 and 2018 (JDDM 66)

H. Yokoyama, H. Maegawa, K. Yamazaki, 2022, BMJ Open Diabetes Research & Care.

A novel oxidized low-density lipoprotein marker, serum amyloid A-LDL, is associated with obesity and the metabolic syndrome.

K. Kotani, A. Shimatsu, H. Yamakage, 2009, Atherosclerosis.

Changes in prescription patterns and doses of oral antidiabetic drugs in Japanese patients with type 2 diabetes (JDDM70)

H. Maegawa, K. Yamazaki, M. Takeuchi, 2022, Journal of diabetes investigation.

Serum Amyloid a Low-Density Lipoprotein Levels and Smoking Status in Obese Japanese Patients

K. Kotani, A. Shimatsu, H. Yamakage, 2011, The Journal of international medical research.

Self-reported rate of eating is significantly associated with body mass index in Japanese patients with type 2 diabetes. Japan Diabetes Clinical Data Management Study Group (JDDM26)

H. Yokoyama, Koichi Iwasaki, H. Sone, 2012, Appetite.

The C42R mutation in the Kir6.2 (KCNJ11) gene as a cause of transient neonatal diabetes, childhood diabetes, or later-onset, apparently type 2 diabetes mellitus.

Yuichiro Yamada, T. Nakahata, N. Inagaki, 2005, The Journal of clinical endocrinology and metabolism.

Changes in oral antidiabetic prescriptions and improved glycemic control during the years 2002–2011 in Japan (JDDM32)

K. Yamazaki, A. Kashiwagi, A. Kanatsuka, 2013, Journal of diabetes investigation.

Pioglitazone treatment and cardiovascular event and death in subjects with type 2 diabetes without established cardiovascular disease (JDDM 36).

K. Sugimoto, H. Yokoyama, H. Maegawa, 2015, Diabetes research and clinical practice.

The status of diabetes control and antidiabetic drug therapy in Japan--a cross-sectional survey of 17,000 patients with diabetes mellitus (JDDM 1).

K. Yamazaki, A. Kanatsuka, Masashi Kobayashi, 2006, Diabetes research and clinical practice.

Relationship between the efficacy of oral antidiabetic drugs and clinical features in type 2 diabetic patients (JDDM38)

Kokichi Tanaka, O. Tomonaga, Y. Kurihara, 2015, Journal of diabetes investigation.

Fear of hypoglycemia and its determinants in insulin-treated patients with type 2 diabetes mellitus

H. Kitaoka, K. Kotani, N. Sakane, 2015, Journal of diabetes investigation.

Current status of oral antidiabetic drug prescribing patterns based on the body mass index for Japanese type 2 diabetes mellitus patients and yearly changes in diabetologists' prescribing patterns from 2002 to 2019 (JDDM61)

H. Yokoyama, H. Maegawa, K. Yamazaki, 2021, Journal of diabetes investigation.

Impaired Awareness of Hypoglycemia in Insulin-Treated Patients with Type 2 Diabetes

H. Kitaoka, K. Kotani, N. Sakane, 2014 .

Prevalence of albuminuria and renal insufficiency and associated clinical factors in type 2 diabetes: the Japan Diabetes Clinical Data Management study (JDDM15).

H. Yokoyama, H. Sone, K. Kawai, 2008, Nephrology, dialysis, transplantation : official publication of the European Dialysis and Transplant Association - European Renal Association.

Time and Costs of Insulin Treatment in the Care of Newly Registered Type 2 Diabetes Patients in Diabetes Clinics Across Japan (JDDM 22)

H. Yokoyama, S. Ikeda, F. Okuguchi, 2011, Japanese clinical medicine.

Cardio-ankle vascular index predicts for the incidence of cardiovascular events in obese patients: a multicenter prospective cohort study (Japan Obesity and Metabolic Syndrome Study: JOMS).

K. Kotani, A. Shimatsu, H. Yamakage, 2015, Atherosclerosis.

Comparison of cystatin C- and creatinine-based estimated glomerular filtration rate to predict coronary heart disease risk in Japanese patients with obesity and diabetes.

K. Kotani, A. Shimatsu, H. Wada, 2015, Endocrine journal.

Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome.

K. Kotani, A. Shimatsu, A. Sugawara, 2011, Clinical journal of the American Society of Nephrology : CJASN.

Observational 6-Month Open-Label Study of Japanese Type 2 Diabetes Patients Switching from NPH Insulin to Insulin Detemir in Basal—Bolus Regimen: 23rd Article of the Japan Diabetes Clinical Data Management Study Group (JDDM23)

O. Tomonaga, H. Yokoyama, N. Abe, 2012, The Journal of international medical research.

Treatment Burden on Once-Weekly Omarigliptin Versus Daily Dipeptidyl Peptidase-4 Inhibitors in Patients with Type 2 Diabetes: Randomized Controlled Trial (ONWARD-DPP4 Study)

H. Seino, H. Akai, N. Kamei, 2023, Diabetes Therapy.

Overall Efficacy and Safety of Sodium-Glucose Cotransporter 2 Inhibitor Luseogliflozin Versus Dipeptidyl-Peptidase 4 Inhibitors: Multicenter, Open-Label, Randomized-Controlled Trial (J-SELECT study)

T. Nishikawa, T. Katsuya, T. Matsuda, 2023, Diabetes Therapy.

Reduced GFR and microalbuminuria are independently associated with prevalent cardiovascular disease in Type 2 diabetes: JDDM study 16

M. Oishi, Hirohito Sone, Hiroki Yokoyama, 2008, Diabetic medicine : a journal of the British Diabetic Association.

Urinary cystatin C as a potential risk marker for cardiovascular disease and chronic kidney disease in patients with obesity and metabolic syndrome.

K. Kotani, A. Shimatsu, A. Sugawara, 2011, Clinical journal of the American Society of Nephrology : CJASN.